Parametric Portfolio Associates’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-303,098
| Closed | -$5.05M | – | 3985 |
|
|
2017
Q3 | $5.05M | Buy |
303,098
+49,978
| +20% | +$813K | 0.01% | 1824 |
|
|
2017
Q2 | $4.53M | Buy |
253,120
+39,962
| +19% | +$747K | 0.01% | 1868 |
|
|
2017
Q1 | $4.27M | Sell |
213,158
-26,522
| -11% | -$618K | 0.01% | 1902 |
|
|
2016
Q4 | $6M | Sell |
239,680
-98,714
| -29% | -$2.33M | 0.01% | 1509 |
|
|
2016
Q3 | $7.91M | Sell |
338,394
-39,427
| -10% | -$926K | 0.01% | 1149 |
|
|
2016
Q2 | $7.55M | Sell |
377,821
-49,896
| -12% | -$931K | 0.01% | 1155 |
|
|
2016
Q1 | $7.25M | Buy |
427,717
+192,121
| +82% | +$3.94M | 0.01% | 1195 |
|
|
2015
Q4 | $5.23M | Buy |
235,596
+17,719
| +8% | +$369K | 0.01% | 1338 |
|
|
2015
Q3 | $3.7M | Buy |
217,877
+65,159
| +43% | +$1.01M | 0.01% | 1366 |
|
|
2015
Q2 | $2.1M | Buy |
152,718
+17,047
| +13% | +$227K | ﹤0.01% | 2203 |
|
|
2015
Q1 | $1.86M | Buy |
135,671
+6,627
| +5% | +$76.5K | ﹤0.01% | 2303 |
|
|
2014
Q4 | $1.36M | Buy |
129,044
+2,336
| +2% | +$27.7K | ﹤0.01% | 2513 |
|
|
2014
Q3 | $1.58M | Buy |
126,708
+26,852
| +27% | +$374K | ﹤0.01% | 2296 |
|
|
2014
Q2 | $1.37M | Buy |
99,856
+9,683
| +11% | +$127K | ﹤0.01% | 2443 |
|
|
2014
Q1 | $1.09M | Buy |
90,173
+22,181
| +33% | +$254K | ﹤0.01% | 2604 |
|
|
2013
Q4 | $836K | Buy |
67,992
+16,957
| +33% | +$199K | ﹤0.01% | 2809 |
|
|
2013
Q3 | $519K | Buy |
51,035
+4,343
| +9% | +$40.6K | ﹤0.01% | 3074 |
|
|
2013
Q2 | $419K | Buy |
+46,692
| New | +$470K | ﹤0.01% | 3106 |
|
Parametric Portfolio Associates's OME Position: Q4 2017 in Review
Parametric Portfolio Associates sold out of Omega Protein (OME) in Q4 2017, closing a stake of 303,098 shares — an estimated $5.05M sold.
Parametric Portfolio Associates first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $7.91M in Q3 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Parametric Portfolio Associates reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Parametric Portfolio Associates sold 303,098 Omega Protein shares in Q4 2017, an estimated $5.05M.
- Parametric Portfolio Associates first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Parametric Portfolio Associates's Omega Protein position peaked at $7.91M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Parametric Portfolio Associates's 13F filing for Q4 2017, filed 14 Feb 2018.